Skip Navigation

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines & 3rd Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts


Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

Menu Search
The Sidney Kimmel Comprehensive Cancer Center

In This Section      

Following Patients for Disease Recurrence

Our team takes a proactive approach to following patients closely for recurrent disease. We believe that it may make a difference in prolonging life and maintaining quality of life if we catch recurrent tumors earlier and treat them effectively. Follow-up appointments are made every three months for the first two to three years, every six months up to 5 years after diagnosis and yearly thereafter.

Myths and Facts of the CA125 test - It’s NOT a screening tool

CA125 is a non-specific blood test that can be abnormal in patients with ovarian cancer as well as many non-cancerous conditions including inflammation of the peritoneal surface. For women who previously have not been diagnosed with ovarian cancer, elevated CA125 could be anything from endometriosis or a bladder infection to presence of menstrual period. It is approved by the FDA as a means of monitoring ovarian cancer, but should not be used as a screening test for the disease, particularly in pre-menopausal women. Currently, the morphologic or anatomical characteristics of the ovary, as seen by ultrasound or computed tomography, are the most accurate means for evaluating a suspected ovarian cancer.


Ask the Expert

Answers to your general questions on a variety of ovarian cancer topics.